244 related articles for article (PubMed ID: 26988293)
1. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
3. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
[TBL] [Abstract][Full Text] [Related]
4. Distinctive EBV infection characteristics in children from a developing country.
Ferressini Gerpe NM; Vistarop AG; Moyano A; De Matteo E; Preciado MV; Chabay PA
Int J Infect Dis; 2020 Apr; 93():139-145. PubMed ID: 32004689
[TBL] [Abstract][Full Text] [Related]
5. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Virol; 2000 Nov; 74(21):9964-71. PubMed ID: 11024124
[TBL] [Abstract][Full Text] [Related]
6. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
7. The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control.
Vistarop AG; Cohen M; Huaman F; Irazu L; Rodriguez M; De Matteo E; Preciado MV; Chabay PA
Med Microbiol Immunol; 2018 Nov; 207(5-6):319-327. PubMed ID: 30046954
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes.
Assadian F; Kamel W; Laurell G; Svensson C; Punga T; Akusjärvi G
PLoS One; 2017; 12(5):e0177275. PubMed ID: 28542273
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence.
Chaganti S; Heath EM; Bergler W; Kuo M; Buettner M; Niedobitek G; Rickinson AB; Bell AI
Blood; 2009 Jun; 113(25):6372-81. PubMed ID: 19351961
[TBL] [Abstract][Full Text] [Related]
11. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
12. Tissue markers of Epstein-Bar virus (EBV) infection in B-cell non-Hodgkin's lymphomas.
Kasprzak A; Spachacz R; Hałoń A; Jeleń M; Stefańska K; Wachowiak J; Trejster E; Zabel M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):639-48. PubMed ID: 17317895
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina.
Lara J; Cohen M; De Matteo E; Aversa L; Preciado MV; Chabay P
J Med Virol; 2014 May; 86(5):845-50. PubMed ID: 24027016
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
15. Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects.
Kwok H; Chan KW; Chan KH; Chiang AK
PLoS One; 2015; 10(3):e0120710. PubMed ID: 25807555
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.
Meru N; Davison S; Whitehead L; Jung A; Mutimer D; Rooney N; Kelly D; Niedobitek G
Mol Pathol; 2001 Aug; 54(4):264-9. PubMed ID: 11477143
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
[TBL] [Abstract][Full Text] [Related]
18. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
